StockDuty ← Dashboard Sep 02, 2026 10:14 PM ET
CatalystFDA/Bio

TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)

Phase 3 EoE success signals major label expansion for Amgen.

Phase 3 EoE success signals major label expansion for Amgen.
Sources